As of Mar 24
| +0.20 / +1.18%|
The 7 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 22.00, with a high estimate of 31.00 and a low estimate of 19.00. The median estimate represents a +28.28% increase from the last price of 17.15.
The current consensus among 8 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.